Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Trinity Biotech (TRIB) over the last 12 years, with Q2 2025 value amounting to $2.8 million.

  • Trinity Biotech's Long-Term Investments changed N/A to $2.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2024, which is 127921.35% up from last year.
  • Trinity Biotech's Long-Term Investments amounted to $2.8 million in Q2 2025.
  • In the past 5 years, Trinity Biotech's Long-Term Investments ranged from a high of $21.8 million in Q4 2021 and a low of $128000.0 during Q4 2022
  • In the last 5 years, Trinity Biotech's Long-Term Investments had a median value of $2.5 million in 2024 and averaged $5.5 million.
  • Per our database at Business Quant, Trinity Biotech's Long-Term Investments soared by 149211.68% in 2021 and then crashed by 9941.32% in 2022.
  • Trinity Biotech's Long-Term Investments (Quarter) stood at $21.8 million in 2021, then tumbled by 99.41% to $128000.0 in 2022, then skyrocketed by 39.06% to $178000.0 in 2023, then soared by 1279.21% to $2.5 million in 2024, then rose by 12.55% to $2.8 million in 2025.
  • Its Long-Term Investments was $2.8 million in Q2 2025, compared to $2.5 million in Q4 2024 and $178000.0 in Q4 2023.